HOXB7 confers epithelial-mesenchymal transition in breast cancer62, promotes malignant progression by activation of TGF signalling63 and lung metastasis64 and renders breast cancer cells resistant to tamoxifen through activation of the EGFR pathway65. Here, EGFR is linked to breast carcinoma.